Cisplatin and carboplatin in combination with etoposide as a treatment for non-small cell lung cancer: the experience of the eortc lung cancer working party

Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung. Report by the radiation therapy oncology group

1982 • 406 citations

Cisplatin and Vindesine Combination Chemotherapy for Advanced Carcinoma of the Lung: A Randomized Trial Investigating Two Dosage Schedules

1981 • 367 citations

Lung Cancer: Progress in Therapeutic Research

1979 • 253 citations

Carboplatin: a very active new cisplatin analog in the treatment of small cell lung cancer.

1985 • 151 citations

Benefits of polychemotherapy in advanced non-small-cell bronchogenic carcinoma

1982 • 143 citations

A randomized study comparing a high and a standard dose of cisplatin in combination with etoposide in the treatment of advanced non-small-cell lung carcinoma.

1986 • 137 citations

Phase II study of JM8, a new platinum analog, in advanced ovarian carcinoma.

1983 • 116 citations

Carboplatin (Paraplatin; JM8) and etoposide (VP-16) as first-line combination therapy for small-cell lung cancer.

1987 • 96 citations

Vindesine and cisplatin combination chemotherapy compared with vindesine as a single agent in the management of non-small cell lung cancer: A randomized study

1984 • 84 citations

High-dose cisplatin with fluid and mannitol-induced diuresis in advanced lung cancer: a phase II clinical trial of the EORTC Lung Cancer Working Party (Belgium).

1980 • 81 citations

Randomized trial comparing vindesine plus cisplatin with vinblastine plus cisplatin in patients with non-small cell lung cancer, with an analysis of methods of response assessment

1985 • 77 citations

Therapy with cisplatin and etoposide for non-small-cell lung cancer.

1986 • 50 citations

Comparison of vindesine plus cisplatin or vindesine plus mitomycin in the treatment of advanced non-small cell lung cancer

1986 • 46 citations

Risk-benefit relationships in cancer clinical trials: the ECOG experience in non-small-cell lung cancer.

1985 • 37 citations

Combination chemotherapy with cisplatin, etoposide, and vindesine in non-small cell lung carcinoma: a clinical trial of the EORTC lung cancer working party.

1983 • 32 citations

Phase II trial of carboplatin in non-small cell lung cancer.

1986 • 31 citations

Phase II study of carboplatin in previously untreated patients with metastatic small cell lung carcinoma

1987 • 30 citations

Combination chemotherapy for non-small cell lung cancer with doxorubicin and mitomycin or cisplatin and etoposide.

1984 • 27 citations

Cis‐dichlorodiammineplatinum (II) and VP 16–213 combination chemotherapy for non‐small cell lung cancer

1981 • 26 citations

Randomized study of cyclophosphamide, doxorubicin, and etoposide (VP16-213) with or without cisplatinum in non-small cell lung cancer.

1983 • 23 citations

Cis-platinum and vindesine in combination in the treatment of non-small cell lung cancer

1985 • 20 citations

cis-platinum and etoposide combination chemotherapy of advanced non-oat cell bronchogenic carcinoma

1983 • 17 citations

Chemotherapy for advanced adenocarcinoma and squamous cell carcinoma of the lung with etoposide and cisplatin.

1984 • 16 citations

Phase II Clinical Trial

2015 • 5 citations